Skip to content
Medical Health Aged Care

KFSH&RC Celebrates 25 Scientists Named in Stanford’s Top 2% Most-Cited Researchers Worldwide

King Faisal Specialist Hospital & Research Centre 2 mins read

E'24-026_BDA_26715

RIYADH, Saudia Arabia, Jan. 16, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre honored 25 scientists who joined Stanford University's prestigious list, marking them among the 'top 2% most-cited scientists' list updated in October 2023.

The recent release recognizes 25 distinguished KFSH&RC scientists, among the top 2% most-cited researchers worldwide in 2021-2022, and acknowledges their overall career accomplishments. This prestigious recognition celebrates the outstanding contributions and impact of KFSH&RC researchers on the global scientific stage, highlighting KFSH&RC's steady commitment to advancing healthcare through novel research. It elevates its international reputation as a pioneer hub for innovative research.

His Excellency Dr. Majid Al Fayyadh, Chief Executive Officer, KFSH&RC, stated: "We are incredibly proud of this recognition, a testament to our firm commitment to advancing healthcare through cutting-edge research and innovation at home and beyond. This new milestone reflects the dedication and expertise of our exceptional team of scientists and medical professionals who continually push the boundaries of knowledge. At KFSH&RC, we remain dedicated to our mission to shape the future of healthcare and contribute to global advancements in the field."

Renowned for its annual compilation, Stanford University highlights the remarkable achievements of scientists whose research has reaped the highest citations in international and scientific journals. The university unveils a list featuring 180,000 researchers representing the top 2% of most-cited scientists globally each year. This compilation covers 22 research fields and 176 subfields, utilizing citation metrics from the Scopus database.

KFSH&RC extends heartfelt congratulations to researchers recognized for the year 2021-2022. Each scientist left an indelible mark in various medical fields. Their contributions exemplify KFSH&RC's commitment to excellence and leadership in healthcare innovation.

This recognition further enhances KFSH&RC's reputation as a holistic healthcare hub, highlighting its dedication to building a resilient healthcare system through continuous research and advancement, in line with Vision 2030.

For more information, please visit www.kfshrc.edu.sa or contact our media team at [email protected].

A photo accompanying this announcement is available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/44867e95-bfa4-49d6-b4c5-123d624d9de3


Primary Logo

More from this category

  • Medical Health Aged Care
  • 07/12/2025
  • 01:41
Takeda Pharmaceutical Company Limited

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera

52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline NEWARK,…

  • Medical Health Aged Care
  • 06/12/2025
  • 02:11
Arthur D. Little

Arthur D. Little and Vega IT Unveil Joint Venture for Digital Innovation

NEW YORK–BUSINESS WIRE– Arthur D. Little (ADL) and Vega IT today announced the formation of Axceler8 Solutions, a 50/50 joint venture created to design,…

  • Contains:
  • Medical Health Aged Care, Women
  • 05/12/2025
  • 10:11
Breast Cancer Trials

Bec’s Christmas wish amid cancer treatment

This Christmas, Bec’s wish is for her daughters to never face a breast cancer diagnosis like she has. “The only thing tougher than telling…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.